Saquinavir
Alternative Names: Fortovase; Invirase; RO 318959; RO 318959/003Latest Information Update: 27 Dec 2024
Price :
$50 *
At a glance
- Originator Roche
- Class Antiretrovirals; Isoquinolines; Quinolines
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed HIV infections
Most Recent Events
- 27 Dec 2024 Regulatory Update: Updated Intro, KDM and dev lines for EU marketing approval withdrawn
- 26 Oct 2007 Final results from a phase IIIb clinical trial (Gemini) added to the adverse events and Viral Infections pharmacodynamics and therapeutic trials sections
- 15 Nov 2006 Interim 24-week results from a phase IIIb clinical trial (Gemini study) in treatment-naive patients with HIV infections have been added to the adverse events and Viral infections therapeutic trials sections